11/2/2023 0 Comments Genmark stockWe consider it positive that insiders have made significant purchases in the last year. The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers). The strong share price rise indicates optimism, so there may be a better opportunity for buyers as the hype fades a bit. It's great to see strong revenue growth, but the question is whether it can be sustained. Meanwhile, the market has paid attention, sending the share price soaring 186% in response. ![]() That's a head and shoulders above most loss-making companies. ![]() In the last year GenMark Diagnostics saw its revenue grow by 47%. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. When a company doesn't make profits, we'd generally expect to see good revenue growth. Arguably revenue is our next best option. GenMark Diagnostics wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). View our latest analysis for GenMark Diagnostics Looking back further, the stock price is 45% higher than it was three years ago. On top of that, the share price is up 72% in about a quarter. ( NASDAQ:GNMK) share price had more than doubled in just one year - up 186%. ![]() For example, the GenMark Diagnostics, Inc. But if you pick the right stock, you can make a lot more than 100%. Unfortunately, investing is risky - companies can and do go bankrupt.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |